Valuation: Diaceutics PLC

Market Cap 171M 229M 204M 189M 322M 21.62B 326M 2.27B 889M 11.36B 859M 842M 36.21B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 163M 219M 195M 180M 308M 20.64B 311M 2.16B 849M 10.85B 821M 803M 34.57B EV / Sales 2026 *
3.5x
EV / Sales 2027 * 2.85x
Free-Float
72%
Yield 2026 *
-
Yield 2027 * -
1 day-1.47%
1 week-0.49%
Current month+5.22%
1 month+18.53%
3 months+52.08%
6 months+22.87%
Current year+57.42%
1 week 200
Extreme 200
210
1 month 170
Extreme 170
210
Current year 125
Extreme 125
210
1 year 125
Extreme 125
210
3 years 82
Extreme 82
210
5 years 74
Extreme 74
210
10 years 74
Extreme 74
210
Manager TitleAgeSince
Chief Executive Officer 42 31/12/2023
Director of Finance/CFO - 17/03/2022
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 30/09/2024
Director/Board Member 42 -
Director/Board Member 42 30/09/2024
Date Insider Type Main position Quantity % Market Cap. Importance
05/05/26 Buy

Chief Financial Officer

90 0.0001%
05/05/26 Free

Chief Financial Officer

90 0.0001%
05/05/26 Free

Executive/Senior Manager

89 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.47%-0.49%+24.77%+119.02% 232M
+0.31%+4.19%+17.46%+76.15% 746B
+1.44%+5.52%+12.04%+76.30% 86.18B
+2.41%+3.30%+6.65%+161.44% 64.97B
+0.11%+1.96%-18.34%+7.02% 48.88B
+0.14%+3.11%+0.62%+78.15% 47.21B
+0.07%-7.76%+64.53%+757.85% 46.99B
+1.95%+3.82%+8.52%+36.43% 31.55B
-0.20%+3.70%+41.79%+71.01% 26.81B
-0.08%+4.65%-61.76%-56.02% 25.66B
Average +0.71%-0.13%+9.63%+132.74% 112.48B
Weighted average by Cap. +0.71%+1.61%+14.65%+102.41%

Financials

2026 *2027 *
Net sales 46.72M 62.57M 55.76M 51.62M 88.02M 5.9B 89.06M 619M 243M 3.1B 235M 230M 9.89B 56.34M 75.46M 67.25M 62.26M 106M 7.12B 107M 746M 293M 3.74B 283M 277M 11.93B
Net income -1.1M -1.47M -1.31M -1.22M -2.07M -139M -2.1M -14.57M -5.72M -73.08M -5.53M -5.41M -233M 2.85M 3.82M 3.4M 3.15M 5.37M 360M 5.43M 37.76M 14.82M 189M 14.32M 14.02M 603M
Net Debt -7.73M -10.35M -9.23M -8.54M -14.56M -977M -14.73M -102M -40.18M -514M -38.83M -38.03M -1.64B -10.4M -13.92M -12.41M -11.49M -19.59M -1.31B -19.82M -138M -54.04M -691M -52.23M -51.14M -2.2B
Projected Income Statement - Annual - Diaceutics PLC
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Date Price Change Volume
21/10/26 GBX 201.50 -1.47% 304,743
20/10/26 GBX 204.50 0.00% 49,913
19/10/26 GBX 204.50 +0.49% 167,477
16/10/26 GBX 203.50 +0.49% 575,986
15/10/26 GBX 202.50 0.00% 210,066
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Diaceutics PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.045GBP
Average target price
2.130GBP
Spread / Average Target
+4.16%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Diaceutics PLC
  1. Stock Market
  2. Stocks
  3. DXRX Stock